Skip to Main Content

Paper Details

Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence.
Br J Ophthalmol
27
2021
VEGF, aflibercept, anti-VEGF, nAMD, neovascular age-related macular degeneration, patients, ranibizumab, vascular endothelial growth factor
Author NameAffiliation
Vincent DaienGui de Chauliac Hospital
Vincent DaienThe Save Sight Institute, Sydney Medical School, The University of Sydney
Robert P FingerUniversity of Bonn
Stephen J TalksRoyal Victoria Infirmary
Tien Yin WongSingapore Eye Research Institute
Tien Yin WongDuke-NUS Medical School
Tien Yin WongSingapore Eye Research Institute
Tien Yin WongDuke-NUS Medical School
  • 1 - 8

Datasets

PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink